SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-015781
Filing Date
2024-02-21
Accepted
2024-02-21 16:30:33
Documents
16
Period of Report
2024-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0200364-8k_aditxt.htm   iXBRL 8-K 26372
2 ENGAGEMENT LETTER DATED FEBRUARY 16, 2024 ea0200364ex10-1_aditxt.htm EX-10.1 46061
3 GRAPHIC ex10-1_001.jpg GRAPHIC 6627
  Complete submission text file 0001213900-24-015781.txt   269931

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20240216.xsd EX-101.SCH 3009
5 XBRL LABEL FILE adtx-20240216_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20240216_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0200364-8k_aditxt_htm.xml XML 3705
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 24660099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)